Drs. Alexandra Zachwieja, Kendra Nordgren, and Cathy McCarty on the Medical School’s Duluth campus are leading the way to develop a virtual course addressing the social determinants of health during COVID-19.
Claudia Cohn, MD, PhD, and Jed Gorlin, MD, discuss the use of convalescent plasma in treating COVID-19 and how to donate if someone has recovered from the virus.
Nic Rider, PhD, and Stephanie Terezakis, MD, are co-principal investigators on a new grant from the Radiation Oncology Institute focused on health disparities in cancer care plaguing the LGBTQ population.
Alessandro Bartolomucci, PhD, recently helped publish a review in Science focused on key themes, emerging parallels and insights of social adversity among humans and other animals.
Hossein Nazari, MD, in the Department of Ophthalmology and Visual Neurosciences, leads a team testing whether or not COVID-19 can be diagnosed with tears. If proven, their discovery may lead to a faster, safer and less painful way to test for the virus.
Jin O-Uchi, MD, PhD, FAHA, FCVS, and other U of M researchers received a new grant to study if magnesium can make a difference in high-risk patients with COVID-19.
First randomized clinical trial of Hydroxychloroquine to prevent COVID-19 following exposure.
Morgan Brisse, a PhD candidate in the Department of Biochemistry, Molecular Biology and Biophysics, talks about her experience in the lab during the COVID-19 pandemic.
Associate Professor Carol Peterson, PhD, and Assistant Professor Annie Haynos, PhD, from the Medical School’s Department of Psychiatry and Behavioral Sciences, explain their groundbreaking research on the links between mental health and eating disorders.
Michael-Paul Schallmo, PhD, studied why people with ASD may experience sensory hypersensitivity and found that differences in visual motion perception in ASD are accompanied by weaker neural suppression in the visual cortex of the brain.